The historical rank and industry rank for Henan Lingrui Pharmaceutical Co's FCF Margin % or its related term are showing as below:
SHSE:600285'
s FCF Margin % Range Over the Past 10 Years
Min: -10.75 Med: 18.42 Max: 28.54
Current: 16.33
During the past 13 years, the highest FCF Margin % of Henan Lingrui Pharmaceutical Co was 28.54%. The lowest was -10.75%. And the median was 18.42%.
SHSE:600285's FCF Margin % is ranked better than 83.49% of 963
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs SHSE:600285: 16.33
Henan Lingrui Pharmaceutical Co FCF Margin % Related Terms
Henan Lingrui Pharmaceutical Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henan Lingrui Pharmaceutical Co FCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Henan Lingrui Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henan Lingrui Pharmaceutical Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Henan Lingrui Pharmaceutical Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Henan Lingrui Pharmaceutical Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henan Lingrui Pharmaceutical Co (SHSE:600285) has a FCF Margin % of 22.67% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Henan Lingrui Pharmaceutical Co and its competitors. This is 23% above median its historical median of 18.42. According to the industry distribution chart, Henan Lingrui Pharmaceutical Co ranks #159 out of 963 companies in the Drug Manufacturers industry, placing it in the top 16.5%.
Is Henan Lingrui Pharmaceutical Co's FCF Margin % too high?
Henan Lingrui Pharmaceutical Co's current FCF Margin % of 22.67% is 23% above median its 10-year median of 18.42. The Drug Manufacturers industry median FCF Margin % is 2.51. Henan Lingrui Pharmaceutical Co's value of 22.67% is 803.2% above this industry median. Based on the distribution chart, Henan Lingrui Pharmaceutical Co ranks #159 out of 963 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Henan Lingrui Pharmaceutical Co has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henan Lingrui Pharmaceutical Co's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Henan Lingrui Pharmaceutical Co ranks #159 out of 963 companies for FCF Margin %. This places Henan Lingrui Pharmaceutical Co in the top 17% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.51. Henan Lingrui Pharmaceutical Co's value of 22.67% is 803.2% above this benchmark. While the company's 10-year median is 18.42 vs. the industry median of 2.51, Henan Lingrui Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henan Lingrui Pharmaceutical Co's current FCF Margin % of 22.67% is 803.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Henan Lingrui Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henan Lingrui Pharmaceutical Co's current FCF Margin % is 22.67%, which is 23% above median its own 10-year median of 18.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henan Lingrui Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co (SHSE:600285) is currently considered Fairly Valued. The stock's GF Value™ is ¥24.39, compared to a current price of ¥22.54 — trading 7.6% below its estimated fair value. The current FCF Margin % is 22.67%, which is 23% above median its 10-year median of 18.42 and 803.2% above the Drug Manufacturers industry median of 2.51. Henan Lingrui Pharmaceutical Co's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Henan Lingrui Pharmaceutical Co (SHSE:600285), the current FCF Margin % is 22.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henan Lingrui Pharmaceutical Co (SHSE:600285) Overvalued in 2026?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥22.54 is trading 7.6% below its estimated GF Value™ of ¥24.39.
GuruFocus considers Henan Lingrui Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:600285:
FCF Margin %: 22.67% (23% above median its 10-year median of 18.42)
GF Value™: ¥24.39 vs. price of ¥22.54 (7.6% below fair value)
Industry Position: 803.2% above the Drug Manufacturers median (#159 of 963)
No single metric tells the full story. See the SHSE:600285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henan Lingrui Pharmaceutical Co Business Description
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
97GF Score
Get the complete analysis for SHSE:600285
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600285 has been successfully added to your 
